Pulmonary/Respiratory Medicine CME

Credits: 1.00 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
April 14, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
April 13, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
April 6, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
April 5, 2021
Credits: 0.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science
March 26, 2021
Credits: 0.50 CME / MOC / CE
Medical Learning Institute, Inc.
Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
March 18, 2021
Credits: 0.50 ABO / CME / MOC
Medical Learning Institute, Inc.
A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
February 25, 2021
Credits: 0.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
February 15, 2021
Credits: 0.50 CME / MOC
Medical Learning Institute, Inc.
Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
January 26, 2021
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
January 26, 2021
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
December 31, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Precision Medicine in Hematologic Cancers: Lessons for Diagnostic and Treatment Protocols in CD30- and CD123-Expressing Disease
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of New Opportunities in Thyroid Cancer: Targeting RET Alterations to Optimize Outcomes
December 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Targeting Ocular Toxicity in Multiple Myeloma: Opportunities for Ophthalmology-Oncology Collaboration
December 29, 2020
Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
December 24, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
December 24, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
December 23, 2020
Credits: 1.50 CME
Penn State College of Medicine
Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
December 23, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Preparing for Personalized Care in Myelodysplastic Syndromes: Integrating Innovative Treatments Into a Cohesive Patient Care Model
December 23, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
December 18, 2020

Pages